Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-08

Clinical Trial Update: C1 Inhibitor Registry in the Treatment of Hereditary Angioedema (HAE) Attacks

View source ↗

Summary

This document reports the completion of a clinical trial registry evaluating C1 inhibitor use for treatment of hereditary angioedema attacks. It provides sponso…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ruconest (conestat alfa)

Snippet

Sponsor: Pharming Technologies B.V. | Conditions: Hereditary Angioedema | Status: COMPLETED